Literature DB >> 20717923

Role of lysyl oxidase propeptide in secretion and enzyme activity.

Jessica L Grimsby1, Hector A Lucero, Philip C Trackman, Katya Ravid, Herbert M Kagan.   

Abstract

Lysyl oxidase (LOX) is secreted as a proenzyme (proLOX) that is proteolytically processed in the extracellular milieu to release the propeptide and mature, active LOX. LOX oxidizes lysyl residues of a number of protein substrates in the extracellular matrix and on the cell surface, which impacts several physiological and disease states. Although the LOX propeptide (LOX-PP) is glycosylated, little is known about the role of this modification in LOX secretion and activity. To gain insight into this issue, cells were transfected with native, full-length LOX cDNA (pre-pro-LOX), the N-glycosylation null pre-[N/Q]pro-LOX cDNA and the deletion mutant pre-LOX cDNA, referred to as secretory LOX, in which mature LOX is targeted to the secretory pathway without its N-terminal propeptide sequence. The results show that glycosylation of the LOX-PP is not required for secretion and extracellular processing of pro-LOX but it is required for optimal enzyme activity of the resulting mature LOX. Complete deletion of the propeptide sequence prevents mature LOX from exiting the endoplasmic reticulum (ER). Taken together, our study points out the requirement of the LOX-PP for pro-LOX exit from the ER and is the first to highlight the influence of LOX-PP glycosylation on LOX enzyme activity.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20717923      PMCID: PMC3858906          DOI: 10.1002/jcb.22845

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  44 in total

Review 1.  ER protein quality control and proteasome-mediated protein degradation.

Authors:  J L Brodsky; A A McCracken
Journal:  Semin Cell Dev Biol       Date:  1999-10       Impact factor: 7.727

2.  Human bleomycin hydrolase regulates the secretion of amyloid precursor protein.

Authors:  I M Lefterov; R P Koldamova; J S Lazo
Journal:  FASEB J       Date:  2000-09       Impact factor: 5.191

3.  A luminal surveillance complex that selects misfolded glycoproteins for ER-associated degradation.

Authors:  Vladimir Denic; Erin M Quan; Jonathan S Weissman
Journal:  Cell       Date:  2006-07-28       Impact factor: 41.582

4.  Ubiquitin-proteasome-dependent degradation of mammalian ER stearoyl-CoA desaturase.

Authors:  Hiroki Kato; Kenjiro Sakaki; Katsuyoshi Mihara
Journal:  J Cell Sci       Date:  2006-06-01       Impact factor: 5.285

5.  Role of a pro-sequence in the secretory pathway of prothyrotropin-releasing hormone.

Authors:  Amparo Romero; Isin Cakir; Charles A Vaslet; Ronald C Stuart; Omar Lansari; Hector A Lucero; Eduardo A Nillni
Journal:  J Biol Chem       Date:  2008-09-08       Impact factor: 5.157

Review 6.  Lysyl oxidase: an oxidative enzyme and effector of cell function.

Authors:  H A Lucero; H M Kagan
Journal:  Cell Mol Life Sci       Date:  2006-10       Impact factor: 9.261

Review 7.  Paradoxical roles for lysyl oxidases in cancer--a prospect.

Authors:  Stacey L Payne; Mary J C Hendrix; Dawn A Kirschmann
Journal:  J Cell Biochem       Date:  2007-08-15       Impact factor: 4.429

8.  Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells.

Authors:  Héctor A Lucero; Katya Ravid; Jessica L Grimsby; Celeste B Rich; Sandra J DiCamillo; Joni M Mäki; Johanna Myllyharju; Herbert M Kagan
Journal:  J Biol Chem       Date:  2008-06-27       Impact factor: 5.157

9.  Lysyl oxidase binds transforming growth factor-beta and regulates its signaling via amine oxidase activity.

Authors:  Phimon Atsawasuwan; Yoshiyuki Mochida; Michitsuna Katafuchi; Masaru Kaku; Keith S K Fong; Katalin Csiszar; Mitsuo Yamauchi
Journal:  J Biol Chem       Date:  2008-10-02       Impact factor: 5.157

10.  Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.

Authors:  Min Wu; Chengyin Min; Xiaobo Wang; Ziyang Yu; Kathrin H Kirsch; Philip C Trackman; Gail E Sonenshein
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

View more
  18 in total

Review 1.  Human copper-dependent amine oxidases.

Authors:  Joel Finney; Hee-Jung Moon; Trey Ronnebaum; Mason Lantz; Minae Mure
Journal:  Arch Biochem Biophys       Date:  2014-01-06       Impact factor: 4.013

Review 2.  Lysyl Oxidase: Its Diversity in Health and Diseases.

Authors:  Suchitra Kumari; Tarun Kumar Panda; Tapaswini Pradhan
Journal:  Indian J Clin Biochem       Date:  2016-05-11

Review 3.  Functional importance of lysyl oxidase family propeptide regions.

Authors:  Philip C Trackman
Journal:  J Cell Commun Signal       Date:  2017-10-30       Impact factor: 5.782

4.  Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity.

Authors:  Kazushi Okada; Hee-Jung Moon; Joel Finney; Alex Meier; Minae Mure
Journal:  Biochemistry       Date:  2018-12-13       Impact factor: 3.162

5.  Activation of cellular chemotactic responses to chemokines coupled with oxidation of plasma membrane proteins by lysyl oxidase.

Authors:  Héctor A Lucero; Joni M Mäki; Herbert M Kagan
Journal:  J Neural Transm (Vienna)       Date:  2011-04-21       Impact factor: 3.575

6.  Post-translational modifications of recombinant human lysyl oxidase-like 2 (rhLOXL2) secreted from Drosophila S2 cells.

Authors:  Li Xu; Eden P Go; Joel Finney; HeeJung Moon; Mason Lantz; Kathryn Rebecchi; Heather Desaire; Minae Mure
Journal:  J Biol Chem       Date:  2013-01-14       Impact factor: 5.157

7.  Effects of High Glucose-Induced Lysyl Oxidase Propeptide on Retinal Endothelial Cell Survival: Implications for Diabetic Retinopathy.

Authors:  Dongjoon Kim; Dayeun Lee; Philip C Trackman; Sayon Roy
Journal:  Am J Pathol       Date:  2019-09-16       Impact factor: 4.307

Review 8.  Bioreactors for Vocal Fold Tissue Engineering.

Authors:  Ana M Gracioso Martins; Andreea Biehl; Daphne Sze; Donald O Freytes
Journal:  Tissue Eng Part B Rev       Date:  2021-03-17       Impact factor: 6.389

9.  GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells.

Authors:  I M Chu; A M Michalowski; M Hoenerhoff; K M Szauter; D Luger; M Sato; K Flanders; A Oshima; K Csiszar; J E Green
Journal:  Oncogene       Date:  2011-09-05       Impact factor: 9.867

10.  Peroxiredoxin-1 Tyr194 phosphorylation regulates LOX-dependent extracellular matrix remodelling in breast cancer.

Authors:  Shireen Attaran; John J Skoko; Barbara L Hopkins; Megan K Wright; Laurel E Wood; Alparslan Asan; Hyun Ae Woo; Adam Feinberg; Carola A Neumann
Journal:  Br J Cancer       Date:  2021-08-13       Impact factor: 9.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.